- Home
- NC vs NMRA Comparison
NC vs NMRA Comparison
Compare NC & NMRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NC
- NMRA
- Stock Information
- Founded
- NC 1913
- NMRA 2019
- Country
- NC United States
- NMRA United States
- Employees
- NC N/A
- NMRA N/A
- Industry
- NC Coal Mining
- NMRA
- Sector
- NC Energy
- NMRA
- Exchange
- NC Nasdaq
- NMRA Nasdaq
- Market Cap
- NC 291.5M
- NMRA 268.5M
- IPO Year
- NC N/A
- NMRA 2023
- Fundamental
- Price
- NC $41.25
- NMRA $1.50
- Analyst Decision
- NC
- NMRA Hold
- Analyst Count
- NC 0
- NMRA 8
- Target Price
- NC N/A
- NMRA $5.83
- AVG Volume (30 Days)
- NC 8.1K
- NMRA 372.9K
- Earning Date
- NC 10-29-2025
- NMRA 11-11-2025
- Dividend Yield
- NC 2.48%
- NMRA N/A
- EPS Growth
- NC N/A
- NMRA N/A
- EPS
- NC 4.23
- NMRA N/A
- Revenue
- NC $265,880,000.00
- NMRA N/A
- Revenue This Year
- NC N/A
- NMRA N/A
- Revenue Next Year
- NC N/A
- NMRA N/A
- P/E Ratio
- NC $9.64
- NMRA N/A
- Revenue Growth
- NC 27.25
- NMRA N/A
- 52 Week Low
- NC $25.52
- NMRA $0.61
- 52 Week High
- NC $45.50
- NMRA $17.19
- Technical
- Relative Strength Index (RSI)
- NC 58.79
- NMRA 49.58
- Support Level
- NC $39.40
- NMRA N/A
- Resistance Level
- NC $41.76
- NMRA $1.70
- Average True Range (ATR)
- NC 1.25
- NMRA 0.08
- MACD
- NC 0.30
- NMRA -0.08
- Stochastic Oscillator
- NC 87.25
- NMRA 81.74
About NC NACCO Industries Inc.
NACCO Industries Inc is a holding company that operates in the mining and natural resource industries. It has three operating segments that are coal mining, North American mining (NA mining), and minerals management. The majority of its revenue is from the coal mining segment. This segment operates surface coal mines under long-term contracts with power generation companies and an activated carbon producer pursuant to a service-based business model. The NA mining segment provides value-add contract mining and services for producers. Minerals management generates income from royalty-based leases by acquiring and promoting oil, gas, and coal mineral interests. The company is diversifying beyond coal mining due to political and economic pressures associated with carbon emissions.
About NMRA Neumora Therapeutics Inc.
Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has scaled its therapeutic pipeline, which currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. Its pipeline includes NMRA-140, NMRA-511, NMRA-266, NMRA-M4R, NMRA-NMDA, NMRA-CK1O, NMRA-NLRP3, and NMRA-GCASE. The group's pipeline is building programs for underserved neuropsychiatric disorders and neurodegenerative diseases.